Correlation Between HP and NervGen Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HP and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HP and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HP Inc and NervGen Pharma Corp, you can compare the effects of market volatilities on HP and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HP with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of HP and NervGen Pharma.

Diversification Opportunities for HP and NervGen Pharma

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between HP and NervGen is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding HP Inc and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and HP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HP Inc are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of HP i.e., HP and NervGen Pharma go up and down completely randomly.

Pair Corralation between HP and NervGen Pharma

Considering the 90-day investment horizon HP Inc is expected to generate 0.86 times more return on investment than NervGen Pharma. However, HP Inc is 1.17 times less risky than NervGen Pharma. It trades about -0.13 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about -0.14 per unit of risk. If you would invest  3,294  in HP Inc on December 27, 2024 and sell it today you would lose (423.00) from holding HP Inc or give up 12.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

HP Inc  vs.  NervGen Pharma Corp

 Performance 
       Timeline  
HP Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days HP Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
NervGen Pharma Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NervGen Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

HP and NervGen Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HP and NervGen Pharma

The main advantage of trading using opposite HP and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HP position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.
The idea behind HP Inc and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences